ACAT inhibitors derived from hetero-Diels-Alder cycloadducts of thioaldehydes

Richard G. Wilde, Jeffrey T. Billheimer, Sandie J. Germain, Elizabeth A. Hausner, Paul C. Meunier, Deborah A. Munzer, Janet K. Stoltenborg, Peter J. Gillies, Deborah L. Burcham, Shiew Mai Huang, John D. Klaczkiewicz, Soo S. Ko, Ruth R. Wexler

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Acyl-CoA:cholesterol acyltransferase (ACAT) is the enzyme largely responsible for intracellular cholesteror esterification. A systemic inhibitor of ACAT is believed to be able to slow or even reverse the atherosclerotic process. Towards that goal, a series of cyclic sulfides, derived from the hetero-Diels-Alder reaction of thioaldehydes with 1,3-dienes, and bearing carboxamide substituents, were prepared and evaluated for in vitro (in several tissues and species) and ex vivo ACAT inhibition. Minor changes in subsequent structure were found to have a significant effect in optimization of the biological activity of this series of compounds.

Original languageAmerican English
Pages (from-to)1493-1513
Number of pages21
JournalBioorganic and Medicinal Chemistry
Volume4
Issue number9
DOIs
StatePublished - 1996
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Keywords

  • Acyl-CoA:cholesterol
  • Acyltransferase
  • Atherosclerosis
  • Cycloaddition
  • thioaldehyde

Fingerprint

Dive into the research topics of 'ACAT inhibitors derived from hetero-Diels-Alder cycloadducts of thioaldehydes'. Together they form a unique fingerprint.

Cite this